FDA Inspection
Siegfried Grafton, Inc.Siegfried Grafton, Inc. – FDA Inspection, Apr 4, 2013
Record Details
This FDA Inspection record concerns Siegfried Grafton, Inc., with an inspection on April 4, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Siegfried Grafton, Inc.
- Inspection Date
- April 4, 2013
- Product Type
- Drugs
View Company Profile
ID · fad55486-3113-4979-9738-85d39544b7f8
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 826305
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Siegfried Grafton, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| August 21, 2026 | Not classified | Minneapolis District Office | |
| August 14, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 15, 2016 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| June 10, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 20, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Siegfried Grafton, Inc.
- FDA Inspection 1335886 - 2026-08-21
- FDA Inspection 1234253 - 2024-08-14
- FDA Inspection 981372 - 2016-07-15
- FDA Inspection 732143 - 2011-06-10
- FDA Inspection 683854 - 2010-09-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.